Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

LeMaitre Vascular, Inc. - Common Stock (NQ:LMAT)

109.17 +2.30 (+2.15%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about LeMaitre Vascular, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
LeMaitre’s (NASDAQ:LMAT) Q1: Beats On Revenue, Guides for Strong Full-Year Sales
Medical device company LeMaitre Vascular (NASDAQ:LMAT) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 12% year on year to $59.87 million. Guidance for next... 
Via StockStory
News headline image
Earnings Scheduled For May 1, 2025 ↗
 
Via Benzinga
News headline image
A Look at LeMaitre Vascular's Upcoming Earnings Report ↗
 
Via Benzinga
News headline image
Earnings To Watch: LeMaitre (LMAT) Reports Q1 Results Tomorrow
Medical device company LeMaitre Vascular (NASDAQ:LMAT) will be reporting results tomorrow after the bell. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence World Trade
News headline image
1 Profitable Stock with Impressive Fundamentals and 2 to Steer Clear Of
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
News headline image
Earnings Scheduled For February 27, 2025 ↗
 
Via Benzinga
News headline image
Novocure Stock Earns 96 RS Rating ↗
On Tuesday, Novocure stock got a positive adjustment to its Relative Strength (RS) Rating to 96, up from 73. 
Via Investor's Business Daily
News headline image
In-Depth Examination Of 4 Analyst Recommendations For LeMaitre Vascular ↗
 
Via Benzinga
News headline image
Q4 Earnings Highlights: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at LeMaitre (NASDAQ:LMAT) and the best and... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
3 Healthcare Stocks Facing Headwinds
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,... 
Via StockStory
Topics Stocks
News headline image
Spotting Winners: Teleflex (NYSE:TFX) And Surgical Equipment & Consumables - Specialty Stocks In Q4
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - specialty stocks fared in... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
Analyst Scoreboard: 4 Ratings For LeMaitre Vascular ↗
 
Via Benzinga
News headline image
Navigating 4 Analyst Ratings For LeMaitre Vascular ↗
 
Via Benzinga
News headline image
Why LEMAITRE VASCULAR INC (NASDAQ:LMAT) qualifies as a quality stock. ↗
A fundamental analysis of (NASDAQ:LMAT): Why Quality Investors May Find LEMAITRE VASCULAR INC (NASDAQ:LMAT) Attractive. 
Via Chartmill
News headline image
2 Reasons to Avoid LMAT and 1 Stock to Buy Instead
Over the past six months, LeMaitre’s shares (currently trading at $83.18) have posted a disappointing 10.5% loss while the S&P 500 was down 4.1%. This may have investors wondering how to approach the... 
Via StockStory
Topics Stocks Supply Chain
News headline image
Winners And Losers Of Q4: Integra LifeSciences (NASDAQ:IART) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
Looking back on surgical equipment & consumables - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Integra LifeSciences (NASDAQ:IART) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
Q4 Earnings Review: Surgical Equipment & Consumables - Specialty Stocks Led by Intuitive Surgical (NASDAQ:ISRG)
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - specialty industry, including Intuitive... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
LeMaitre (NASDAQ:LMAT) Misses Q4 Sales Targets, Stock Drops 11%
Medical device company LeMaitre Vascular (NASDAQ:LMAT) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 14% year on year to $55.72 million. Next quarter’s revenue guidance of... 
Via StockStory
News headline image
What To Expect From LeMaitre’s (LMAT) Q4 Earnings
Medical device company LeMaitre Vascular (NASDAQ:LMAT) will be announcing earnings results tomorrow after the bell. Here’s what to expect. 
Via StockStory
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Inari Medical Stock Gets RS Rating Upgrade ↗
On Wednesday, Inari Medical stock received an upgrade to its Relative Strength (RS) Rating, from 65 to 72. 
Via Investor's Business Daily
News headline image
ResMed Is 80 And 80: Hits 80-Plus Relative Strength Rating After Rising 80% In A Year ↗
ResMed also boasts a superb 96 EPS Rating out of 99, putting it in the top 4% of all companies for recent and long-term profit growth. 
Via Investor's Business Daily
News headline image
Apple To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday ↗
 
Via Benzinga
News headline image
This Synopsys Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗
 
Via Benzinga
News headline image
LMAT Stock Earnings: LeMaitre Vascular Beats EPS, Beats Revenue for Q2 2024 ↗
LMAT stock results show that LeMaitre Vascular beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Staar Surgical Stock Earns RS Rating Upgrade ↗
On Thursday, lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 87 from 77. 
Via Investor's Business Daily
News headline image
Stryker Stock Sees RS Rating Treks Higher To 71 ↗
Stryker stock saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, with an increase from 63 to 71. 
Via Investor's Business Daily
News headline image
Sell In May And Go Away? – April Dividend Income Report ↗
The “Sell in May and Go Away” adage is wrong for most investors. 
Via Talk Markets
News headline image
LMAT Stock Earnings: LeMaitre Vascular Beats EPS, Beats Revenue for Q1 2024 ↗
LMAT stock results show that LeMaitre Vascular beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Inspire Medical Systems Stock Sees IBD RS Rating Rise To 78 ↗
On Tuesday, Inspire Medical Systems stock earned an upgrade to its Relative Strength (RS) Rating, from 69 to 78. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.